Please select the option that best describes you:
Would you still consider Omalizumab for CSU with Angioedema in a patient with Factor V Leiden Deficiency?
Omalizumab has been reported as a possible provoking factor for Venous Thromboembolism.
Omalizumab has been reported as a possible provoking factor for Venous Thromboembolism.